EPSC Pluripotent Stem Cell Medium

Proprietary chemically limited medium (serum free)
 

Patent Portfolio

Core patents cover China, the U.S., Japan, and Europe (WO 2020/200071 A1)

​

Technical Advantages

• Totipotency: EPSCs can differentiate into all cell types in both embryonic and extra-embryonic tissues, providing a broad application prospect for regenerative medicine.​

• ​Efficient gene editing: Streamlined process enabling knockout, knock-in, and point mutations, speeding up disease model development and drug screening.​

• High Stability: Comparable quality to embryonic stem cells (ESCs), with low heterogeneity, ensuring consistency in experiments and treatments.​

• Low-Cost Mass Production: Reduces production time by 50% and costs by 30%, enhancing market competitiveness and promoting technology adoption.​

      Product Line​​​